Cargando…
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716365/ https://www.ncbi.nlm.nih.gov/pubmed/33256394 http://dx.doi.org/10.3324/haematol.2020.262006 |
| _version_ | 1783619144659238912 |
|---|---|
| author | Chonat, Satheesh Graciaa, Sara Shin, H. Stella Newton, Joanna G. Quarmyne, Maa-Ohui Boudreaux, Jeanne Tang, Amy Zerra, Patricia E. Rollins, Margo R. Josephson, Cassandra D. Brown, Clark Joiner, Clinton H. Fasano, Ross M. Stowell, Sean R. |
| author_facet | Chonat, Satheesh Graciaa, Sara Shin, H. Stella Newton, Joanna G. Quarmyne, Maa-Ohui Boudreaux, Jeanne Tang, Amy Zerra, Patricia E. Rollins, Margo R. Josephson, Cassandra D. Brown, Clark Joiner, Clinton H. Fasano, Ross M. Stowell, Sean R. |
| author_sort | Chonat, Satheesh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7716365 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77163652020-12-10 Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease Chonat, Satheesh Graciaa, Sara Shin, H. Stella Newton, Joanna G. Quarmyne, Maa-Ohui Boudreaux, Jeanne Tang, Amy Zerra, Patricia E. Rollins, Margo R. Josephson, Cassandra D. Brown, Clark Joiner, Clinton H. Fasano, Ross M. Stowell, Sean R. Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-07-30 /pmc/articles/PMC7716365/ /pubmed/33256394 http://dx.doi.org/10.3324/haematol.2020.262006 Text en Copyright© 2020 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Chonat, Satheesh Graciaa, Sara Shin, H. Stella Newton, Joanna G. Quarmyne, Maa-Ohui Boudreaux, Jeanne Tang, Amy Zerra, Patricia E. Rollins, Margo R. Josephson, Cassandra D. Brown, Clark Joiner, Clinton H. Fasano, Ross M. Stowell, Sean R. Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| title | Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| title_full | Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| title_fullStr | Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| title_full_unstemmed | Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| title_short | Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| title_sort | eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716365/ https://www.ncbi.nlm.nih.gov/pubmed/33256394 http://dx.doi.org/10.3324/haematol.2020.262006 |
| work_keys_str_mv | AT chonatsatheesh eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT graciaasara eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT shinhstella eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT newtonjoannag eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT quarmynemaaohui eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT boudreauxjeanne eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT tangamy eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT zerrapatriciae eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT rollinsmargor eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT josephsoncassandrad eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT brownclark eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT joinerclintonh eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT fasanorossm eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease AT stowellseanr eculizumabforcomplementmediatedthromboticmicroangiopathyinsicklecelldisease |